Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...